ArticleFrontiers in oncology2022

Combining serum peptide signatures with International Federation of Gynecology and Obstetrics (FIGO) risk score to predict the outcomes of patients with gestational trophoblastic neoplasia (GTN) after first-line chemotherapy.

Fei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.